Trial Profile
A phase dose escalation study investigating the effect of Efatutazone in Japanese patients suffering with metastatic solid tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Efatutazone (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 04 Dec 2015 New trial record